Amgen
AMGN
2,391 hedge funds and large institutions have $90.1B invested in Amgen in 2023 Q2 according to their latest regulatory filings, with 129 funds opening new positions, 993 increasing their positions, 926 reducing their positions, and 154 closing their positions.
30% more call options, than puts
Call options by funds: $1.54B | Put options by funds: $1.18B
7% more repeat investments, than reductions
Existing positions increased: 993 | Existing positions reduced: 926
0.55% less ownership
Funds ownership: 76.43% → 75.88% (-0.55%)
2% less funds holding
Funds holding: 2,435 → 2,391 (-44)
8% less capital invested
Capital invested by funds: $98.3B → $90.1B (-$8.26B)
16% less first-time investments, than exits
New positions opened: 129 | Existing positions closed: 154
32% less funds holding in top 10
Funds holding in top 10: 65 → 44 (-21)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$257M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$236M |
| 3 |
Barclays
London,
United Kingdom
|
+$207M |
| 4 |
Morgan Stanley
New York
|
+$183M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$178M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$524M |
| 2 |
BlackRock
New York
|
-$424M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$379M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$375M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$318M |
AMGN Hedge Fund Activity: Q2 2023 in Review
2,391 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2023, worth a combined $90.1B — down 8.4% from $98.3B a quarter earlier.
Sellers outnumbered buyers: 154 funds closed out of AMGN and 129 opened new positions — a net loss of 25 holders — while 926 trimmed existing stakes and 993 added.
The largest buyer was Franklin Resources, adding an estimated $257M. The largest seller was Capital Research Global Investors, cutting an estimated $524M.
- 2,391 institutional investors held Amgen (AMGN) as of Q2 2023, down from 2,435 in Q1 2023.
- Funds reported $90.1B of Amgen stock for Q2 2023, down 8.4% quarter-over-quarter.
- 129 funds opened new Amgen positions in Q2 2023 and 154 closed out, a net change of -25 holders.
- The largest Amgen buyer in Q2 2023 was Franklin Resources, an estimated $257M added.
- The largest Amgen seller in Q2 2023 was Capital Research Global Investors, an estimated $524M sold.
Based on aggregated 13F filings for Q2 2023.